GlassScriptPhysician profile
Namita Garg
NPI 1013306885
$2,591.90
in general payments reported to CMS, 2019-2025
7 companies · $59.15 in 2025
The $59.15 reported for 2025 was less than what a typical Neurology With Special Qualifications In Child Neurology provider received nationally (typical 2025 total: $275).
See the full distribution for Neurology with Special Qualifications in Child Neurology
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $1,288 · 2022: $83.62 · 2023: $247 · 2024: $914 · 2025: $59.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $982 · Travel and Lodging: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $982.35 |
| Travel and Lodging | $237.63 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $2,133.23 | 2020-2024 | Vns Therapy |
| Neurelis, INC. | $152.87 | 2023 | Valtoco |
| Ucb, INC. | $152.38 | 2024 | Fintepla, Briviact |
| Sarepta Therapeutics, INC. | $63.92 | 2023 | Elevidys |
| Ptc Therapeutics, INC. | $30.35 | 2023 | Emflaza |
| Alexion Pharmaceuticals, INC. | $29.87 | 2025 | |
| Abbvie INC. | $29.28 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Namita Garg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.